Dosage forms for oral administration and methods of treatment using the same

a technology of effective agents and dosage forms, applied in the direction of drug compositions, enzymology, metabolism disorders, etc., can solve the problems of medical privacy, children's potential stigmatization of children by peers, and subjects often experience difficulty in complying with this administration schedule, etc., to achieve effective and prolonged treatment, easy ingested

a technology of effective agents and dosage forms, applied in the direction of drug compositions, enzymology, metabolism disorders, etc., can solve the problems of medical privacy, children's potential stigmatization of children by peers, and subjects often experience difficulty in complying with this administration schedule, etc., to achieve effective and prolonged treatment, easy ingested

US20130243871A1Inactive Publication Date: 2013-09-19NEOS THERAPEUTICS LP

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dosage forms for oral administration and methods of treatment using the same
  • Dosage forms for oral administration and methods of treatment using the same
  • Dosage forms for oral administration and methods of treatment using the same

Examples

Experimental program
Comparison scheme
Effect test

example 1

Loading the Resin Particles with Drug

[0168]The invention relates pharmaceutical compositions comprising drug-resin particles and the methods of making these compositions. This example provides an exemplary method of loading amphetamines onto resin particles. FIG. 1 depicts this loading method.

[0169]In a kettle, amphetamine sulfate and dextroamphetamine sulfate are mixed in purified water until fully dissolved. AMBERLITE IRP 69 resins are added to the kettle and mixed. The solution is filtered through a 20 μm filter (Grade 54), then again through a 8 μm filter (Grade 540). The loaded resinate is collected on the filter paper during each filtration.

[0170]In a kettle, polyethylene glycol is mixed in purified water until fully dissolved. After it is completely dissolved, the loaded resinate is added, and the solution is mixed until uniform. The solution is filtered through a 20 μm filter (Grade 54), then again through a 8 μm filter (Grade 540). The loaded resinate / PEG is collected on th...

example 2

Coating Drug-Resin Particles

[0174]The pharmaceutical compositions of the invention may comprise a coated and uncoated plurality of drug-resin particles. The coated drug-resin particles provide the delayed or triggered-release portion of the composition. This example provides an exemplary method of preparing a polymer coating for the coated drug-resin particles.

[0175]A clean, stainless steel container is pre-weighed. Acetone and ethanol are added to the container. Plasticizer is then added to the container and mixed until dispersed. A coating polymer such as HPMC, is slowly added to the container while mixing. The polymer solution is continuously stirred for at least an hour and until all of the solids are dissolved. This coating solution is continuously stirred during the coating process. The loaded resinate of Example 1 may be coated (e.g., in a wurster coater) with this coating solution to prepare coated drug-resin complexes.

example 3

Loading Resin Particles with Drug and Coating the Drug-Resin Particles

[0176]The methods of Examples 1 and 2 may be combined to prepare the pharmaceutical compositions of the invention. In particular, drug-resin particles may be prepared using the method of Example 1, and those drug-resin particles to be used as the delayed release portion of the composition may be coated with a polymer coating prepared by the method of Example 2. The particles may be dried and mixed in a V-blender. The specific ratio of immediate release and delayed release particles may vary as described below.

[0177]Once the resin particles are loaded, coated, and mixed, the resulting drug-resin particles may be used in any suitable dosage form (e.g., suspension, chewable composition, orally disintegrating composition, capsule, tablet, etc.).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
timeaaaaaaaaaa
particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention relates to dosage forms that provide prolonged therapy. In particular, the invention relates to dosage forms including various pluralities of drug-containing resin particles. The invention also relates to methods of making these dosage forms and methods of treating using these dosage forms.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a continuation-in-part of International Application No. PCT / US2012 / 044698, filed Jun. 28, 2012, which claims priority to U.S. Provisional Application No. 61 / 502,189, filed Jun. 28, 2011, and U.S. Provisional Application No. 61 / 528,554, filed Aug. 29, 2011, the disclosures of each of which are hereby incorporated by reference in their entireties.BACKGROUND OF THE INVENTION[0002](a) Field of the Invention[0003]The invention relates to Attention Deficit Hyperactivity Disorder (ADHD) effective agent dosage forms that both facilitate oral ingestion and provide an effective treatment over a prolonged period of time. In particular, the invention provides for pharmaceutical compositions having a first and second plurality of drug-resin particles, where the first plurality of drug-resin particles does not have a delayed release coating and the second plurality of drug-resin particles does have a delayed release coating, where t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
19 Sep 2013
Publication
US20130243871A1
IPC
A61K9/14
CPC
A61K9/0056; A61K47/48184; A61K31/137; A61K31/4458; A61K9/14; A61K9/146; C12N9/2402; A61K9/5084
Inventors
TENGLER, MARK; MCMAHEN, RUSSELL